Search by Drug Name or NDC
NDC 60219-2045-03 theophylline 300 mg/1 Details
theophylline 300 mg/1
theophylline is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals NY LLC. The primary component is THEOPHYLLINE ANHYDROUS.
MedlinePlus Drug Summary
Theophylline is used to prevent and treat wheezing, shortness of breath, and chest tightness caused by asthma, chronic bronchitis, emphysema, and other lung diseases. It relaxes and opens air passages in the lungs, making it easier to breathe.
Related Packages: 60219-2045-03Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Theophylline
Product Information
| NDC | 60219-2045 |
|---|---|
| Product ID | 60219-2045_8d9dfe98-c0ba-44aa-a349-33c8d0a8bbdf |
| Associated GPIs | |
| GCN Sequence Number | 000093 |
| GCN Sequence Number Description | theophylline anhydrous TAB ER 12H 300 MG ORAL |
| HIC3 | A1B |
| HIC3 Description | XANTHINES |
| GCN | 00413 |
| HICL Sequence Number | 000025 |
| HICL Sequence Number Description | THEOPHYLLINE ANHYDROUS |
| Brand/Generic | Generic |
| Proprietary Name | theophylline |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | theophylline |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 300 |
| Active Ingredient Units | mg/1 |
| Substance Name | THEOPHYLLINE ANHYDROUS |
| Labeler Name | Amneal Pharmaceuticals NY LLC |
| Pharmaceutical Class | Methylxanthine [EPC], Xanthines [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA216276 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 60219-2045-03 (60219204503)
| NDC Package Code | 60219-2045-3 |
|---|---|
| Billing NDC | 60219204503 |
| Package | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60219-2045-3) |
| Marketing Start Date | 2023-03-27 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |